Self-reported and Pharmacologic Adherence During a Demonstration Project on HIV Pre-exposure Prophylaxis among Men who have Sex with Men in Benin

Background and aim. The effectiveness of oral pre-exposure prophylaxis (PrEP) for HIV prevention relies on Adherence. Accordingly, the aim of this study was to compare self-reports that are commonly used in sub-Saharan Africa to monitor adherence with dried blood spots-based results. Materials and methods. The study was part of an oral PrEP demonstration project conducted from August 2020 to December 2021 among 204 men who have sex with other men in Benin. The Mc Nemar test and bivariate log-binomial regression models using the GENMOD procedure were performed to compare adherence levels and explore the association between pharmacologic adherence and four indicators for oral PrEP initiation in Benin. Results. Only 46% and 24.3% of men who provided dried blood spots had detectable drugs levels at month-6 and month-12, respectively. At month-6, perfect adherence for daily PrEP was 92% (self-reports) and 10% (pharmacologic measure; p-value<0.0001) and for event-driven, 49% (self-reports) and 31% (pharmacologic measure; p-value=0.008). At month-12, the corresponding values were 94% and 5% (p<0.0001), and 40% and 27% (p=0.005), respectively. In bivariate analyses, the p-values estimating the association between HIV risk factors and pharmacologic perfect adherence (≥1450 fmol/punch) were 0.173 for consistent condom use, 0.303 for NG and/or CT infections, 0.447 for drug or alcohol consumption, and 0.129 for multiple sexual partnership. Similar results were obtained for partial adherence (≥800 fmol/punch). In post-hoc analyses, three HIV seroconversions were observed in men with a pharmacologic drug concentration <400 fmol/punch. Conclusions. Adherence was generally low and self-reported adherence tended to overestimate pharmacologic adherence. Oral PrEP should be implemented along with continuous adherence support interventions and other HIV prevention tools, including injectable PrEP, so that people can choose the method that adjust the best to their daily life conditions.

Authors

Publication Details

Journal
Journal of Clinical Research and Reports
Published
2024-12-18
DOI
https://doi.org/10.31579/2690-1919/457
Primary Topic
HIV/AIDS Research and Interventions
Type
article
Field-Weighted Citation Impact
0.00
Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
article

Self-reported and Pharmacologic Adherence During a Demonstration Project on HIV Pre-exposure Prophylaxis among Men who have Sex with Men in Benin

Souleymane Diabaté
Journal of Clinical Research and Reports
HIV/AIDS Research and Interventions
article

Self-reported and Pharmacologic Adherence During a Demonstration Project on HIV Pre-exposure Prophylaxis among Men who have Sex with Men in Benin

Souleymane Diabaté
article en

Abstract

Background and aim. The effectiveness of oral pre-exposure prophylaxis (PrEP) for HIV prevention relies on Adherence. Accordingly, the aim of this study was to compare self-reports that are commonly used in sub-Saharan Africa to monitor adherence with dried blood spots-based results. Materials and methods. The study was part of an oral PrEP demonstration project conducted from August 2020 to December 2021 among 204 men who have sex with other men in Benin. The Mc Nemar test and bivariate log-binomial regression models using the GENMOD procedure were performed to compare adherence levels and explore the association between pharmacologic adherence and four indicators for oral PrEP initiation in Benin. Results. Only 46% and 24.3% of men who provided dried blood spots had detectable drugs levels at month-6 and month-12, respectively. At month-6, perfect adherence for daily PrEP was 92% (self-reports) and 10% (pharmacologic measure; p-value<0.0001) and for event-driven, 49% (self-reports) and 31% (pharmacologic measure; p-value=0.008). At month-12, the corresponding values were 94% and 5% (p<0.0001), and 40% and 27% (p=0.005), respectively. In bivariate analyses, the p-values estimating the association between HIV risk factors and pharmacologic perfect adherence (≥1450 fmol/punch) were 0.173 for consistent condom use, 0.303 for NG and/or CT infections, 0.447 for drug or alcohol consumption, and 0.129 for multiple sexual partnership. Similar results were obtained for partial adherence (≥800 fmol/punch). In post-hoc analyses, three HIV seroconversions were observed in men with a pharmacologic drug concentration <400 fmol/punch. Conclusions. Adherence was generally low and self-reported adherence tended to overestimate pharmacologic adherence. Oral PrEP should be implemented along with continuous adherence support interventions and other HIV prevention tools, including injectable PrEP, so that people can choose the method that adjust the best to their daily life conditions.

Journal of Clinical Research and ReportsVol. 17(2)
Good health and well-being
Openalex Percentile: Top 71%
HIV/AIDS Research and Interventions
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.

Self-reported and Pharmacologic Adherence During a Demonstration Project on HIV Pre-exposure Prophylaxis among Men who have Sex with Men in Benin — Souleymane Diabaté · Journal of Clinical Research and Reports (2024) | TGRS Research Map | TGRS